Top Stories

The acquisition takes RAYUS to approximately $140m in EBITDA as it inherits eight new radiology centers and a new subspecialist partnership in South Florida.

PS Logistics doubled its EBITDA during OEP's three-year investment, executing 13 strategic add-on acquisitions.

The PE-backed CDMO grows its mix of work as it gains significant capabilities in lyophilization, an important manufacturing process commonly used in the fast-growing biologics market.

As the life sciences industry increasingly embraces digital marketing strategies, companies like Intouch are seeing growth and attracting private equity interest.

The New York firm looks to unlock more value at a $30 million-in-EBITDA platform comprising a chronic pain management and renal nutrition business.

The growth investment aims to unlock significant multi-market expansion at Bond Vet, which sources liken to a tech-powered CityMD for veterinarians, pet parents and their pets.

In the crowded markets, GPs have more options than ever to achieve exits for their portfolio companies.

The investors will fuel expansion of the eating disorder treatment platform both physically and virtually, while supporting further diversification into other behavioral health conditions.

PPC inked seven acquisitions under MSCP's about four-year investment, pushing the flexible packaging company's EBITDA close to $50m.

Less than four years ago, the Santa Monica PE giant carved out the healthcare software business from Wolters Kluwer for $180m in cash.